These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 29155852)

  • 1. The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions.
    Koessler J; Schwarz M; Weber K; Etzel J; Koessler A; Boeck M; Kobsar A
    PLoS One; 2017; 12(11):e0188193. PubMed ID: 29155852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing phosphodiesterase 5A activity contributes to platelet cGMP accumulation during storage of apheresis-derived platelet concentrates.
    Kobsar A; Putz E; Yilmaz P; Weinig E; Boeck M; Koessler J
    Transfusion; 2014 Apr; 54(4):1008-14. PubMed ID: 23909451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Purinergic Receptor Expression and Function for Reduced Responsiveness to Adenosine Diphosphate in Washed Human Platelets.
    Koessler J; Hermann S; Weber K; Koessler A; Kuhn S; Boeck M; Kobsar A
    PLoS One; 2016; 11(1):e0147370. PubMed ID: 26808867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.
    Bijak M; Szelenberger R; Dziedzic A; Saluk-Bijak J
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29439388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin by activation of adenosine A
    Rukoyatkina N; Shpakova V; Bogoutdinova A; Kharazova A; Mindukshev I; Gambaryan S
    Biochem Biophys Res Commun; 2022 Jan; 586():20-26. PubMed ID: 34823218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory significance of defective P2Y(12) pathway function in patients with myeloproliferative neoplasms: a pilot study.
    Chang H; Shih LY; Michelson AD; Dunn P; Frelinger AL; Wang PN; Kuo MC; Lin TL; Wu JH; Tang TC
    Acta Haematol; 2013; 130(3):181-7. PubMed ID: 23751441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide.
    Kirkby NS; Lundberg MH; Chan MV; Vojnovic I; Solomon AB; Emerson M; Mitchell JA; Warner TD
    Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15782-7. PubMed ID: 24003163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.
    Bal Dit Sollier C; Berge N; Boval B; Dubar M; Drouet L
    Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.
    Bagoly Z; Sarkady F; Magyar T; Kappelmayer J; Pongrácz E; Csiba L; Muszbek L
    PLoS One; 2013; 8(7):e69417. PubMed ID: 23844259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Cold Storage on Adenosine Diphosphate-Mediated Platelet Responsiveness.
    Koessler J; Klingler P; Niklaus M; Weber K; Koessler A; Boeck M; Kobsar A
    TH Open; 2020 Jul; 4(3):e163-e172. PubMed ID: 32803122
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
    Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
    Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of long-term proteasome inhibition on platelet responsiveness mediated by bortezomib.
    Klingler P; Niklaus M; Koessler J; Weber K; Koessler A; Boeck M; Kobsar A
    Vascul Pharmacol; 2021 Jun; 138():106830. PubMed ID: 33422688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y
    Gündüz D; Tanislav C; Sedding D; Parahuleva M; Santoso S; Troidl C; Hamm CW; Aslam M
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.
    Iyú D; Glenn JR; White AE; Fox SC; Dovlatova N; Heptinstall S
    Platelets; 2011; 22(7):504-15. PubMed ID: 21591981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP.
    Lee DH; Kwon HW; Kim HH; Lim DH; Nam GS; Shin JH; Kim YY; Kim JL; Lee JJ; Kwon HK; Park HJ
    Arch Pharm Res; 2015 Jan; 38(1):81-97. PubMed ID: 25001901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition.
    Aradi D; Magyarlaki T; Tokés-Füzesi M; Rideg O; Vorobcsuk A; Komócsi A
    Platelets; 2010; 21(7):563-70. PubMed ID: 20642320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-platelet and anti-thrombogenic effects of shikimic acid in sedentary population.
    Veach D; Hosking H; Thompson K; Santhakumar AB
    Food Funct; 2016 Aug; 7(8):3609-16. PubMed ID: 27480079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.